DEFENSIN THERAPEUTICS APS has a total of 54 patent applications. It decreased the IP activity by 38.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are EVANS-FREKE STEPHEN, ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS and ALFACYTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | China | 5 | |
#6 | Republic of Korea | 5 | |
#7 | Singapore | 5 | |
#8 | WIPO (World Intellectual Property Organization) | 5 | |
#9 | Brazil | 4 | |
#10 | Mexico | 2 | |
#11 | Russian Federation | 2 | |
#12 | Japan | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Nordkild Peter | 37 |
#2 | Kjaerulff Søren | 14 |
#3 | Wehkamp Jan | 10 |
#4 | Kjaerulff Soren | 9 |
#5 | Norkild Peter | 6 |
#6 | Peter Nordkild | 5 |
#7 | Andersen Birgitte | 5 |
#8 | Søren Kjærulff | 4 |
#9 | Brinch Karoline Sidelmann | 3 |
#10 | Kjarulff Soren | 3 |
Publication | Filing date | Title |
---|---|---|
BR112020010180A2 | B-DEFENSIN AND / OR A-HUMAN DEFENSIN FOR USE IN PREVENTING OR TREATING GRAFT DISEASE AGAINST ACUTE HOST | |
CN111556759A | Maturation of mucosal defenses and intestinal/pulmonary function in premature infants | |
AU2017376400A1 | Methods for treating inflammatory conditions of the lungs | |
KR20190003592A | Treatment of liver, biliary and pancreatic disorders | |
RU2738265C2 | Methods for modulating intestinal microbiota | |
EP2729159A2 | Oral treatment of inflammatory bowel disease |